Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric R Fearon

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Plos One|July 21, 2012
Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitisWei Dou, Subhajit Mukherjee, Hao Li, et al.
BMC Bioinformatics|February 12, 2005
Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling dataKerby Shedden, Wei Chen, Rork Kuick, et al.
Cancer Research|December 7, 2019
Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human CounterpartsKevin W McCool, Zachary T Freeman, Yali Zhai, et al.
Cancer Cell|June 28, 2002
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformationFrank T Kolligs, Marvin T Nieman, Ira Winer, et al.
Plos Genetics|November 4, 2015
Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian EpitheliumYing Feng, Naoya Sakamoto, Rong Wu, et al.
The American Journal of Pathology|April 23, 2003
Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomasRong Wu, Lin Lin, David G Beer, et al.
The Journal of Clinical Investigation|April 3, 2025
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 inductionYing Feng, Ningxin Zhu, Karan Bedi, et al.
Oncoimmunology|March 21, 2022
DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathwayDanfeng Sun, Weichao Wang, Fangfang Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomasKerby A Shedden, Malti P Kshirsagar, Donald R Schwartz, et al.
Gastroenterology|January 21, 2014
Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humansSoumen K Manna, Naoki Tanaka, Kristopher W Krausz, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Plos One|July 21, 2012
Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitisWei Dou, Subhajit Mukherjee, Hao Li, et al.
BMC Bioinformatics|February 12, 2005
Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling dataKerby Shedden, Wei Chen, Rork Kuick, et al.
Cancer Research|December 7, 2019
Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human CounterpartsKevin W McCool, Zachary T Freeman, Yali Zhai, et al.
Cancer Cell|June 28, 2002
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformationFrank T Kolligs, Marvin T Nieman, Ira Winer, et al.
Plos Genetics|November 4, 2015
Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian EpitheliumYing Feng, Naoya Sakamoto, Rong Wu, et al.
The American Journal of Pathology|April 23, 2003
Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomasRong Wu, Lin Lin, David G Beer, et al.
The Journal of Clinical Investigation|April 3, 2025
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 inductionYing Feng, Ningxin Zhu, Karan Bedi, et al.
Oncoimmunology|March 21, 2022
DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathwayDanfeng Sun, Weichao Wang, Fangfang Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomasKerby A Shedden, Malti P Kshirsagar, Donald R Schwartz, et al.
Gastroenterology|January 21, 2014
Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humansSoumen K Manna, Naoki Tanaka, Kristopher W Krausz, et al.
Pageof 12